Albert David Q4 Results
- BSE: 524075
- NSE: ALBERTDAVD
- ISIN: INE155C01010
- Sector: Biotechnology & Drugs
BSE
789.20
-12.35 (-1.54%)
-12.35 (-1.54%)Volume25.00
Updated: Tue 11 Aug, 2026 | 09:15:55
NSE
802-2.00 (-0.25%)
-2.00 (-0.25%)Volume3.47 K
Updated: Tue 11 Aug, 2026 | 10:31:34
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹85.86 Cr.(14.65%)
- Operating Profit₹0.03 Cr.(NA%)
- Profit After Tax₹-21.43 Cr.(107.54%)
- Operating Margin0.04%(NA%)
Note: Comparison is on YoY basis
Quarterly - Albert David Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 85.83 | 81.53 | 5.28% | 81.32 | 5.37% |
| Depreciation/ Amortization | 2.72 | 2.42 | 12.33% | 1.83 | 49.79% |
| Operating Income | 0.03 | 8.40 | -99.60% | 7.74 | 0.00% |
| Net Income | -21.43 | 15.30 | 0.00% | 12.91 | 107.54% |
| Other Operating Expenses Total | 29.93 | 27.37 | 9.36% | 26.51 | 8.33% |
| Net Income Before Taxes | -25.23 | 19.90 | 0.00% | 18.11 | 113.69% |
| Total Revenue | 85.86 | 89.93 | -4.52% | 89.06 | 14.65% |
| Selling/ General/ Admin Expenses Total | 23.08 | 23.90 | -3.43% | 22.72 | 1.75% |
| Diluted Normalized EPS | -37.55 | 26.81 | 0.00% | 22.63 | 107.56% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.